LVS vs MGRX · P/E 28, rev $6.74B vs rev $456.0K
Las Vegas Sands Corp (LVS) versus Mangoceuticals, Inc. Common Stock (MGRX) — a side-by-side from cached financials, not a winner call.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
LVS currently screens at market cap $35.70B and trailing P/E 28.3. MGRX currently screens at market cap $16.3M.
Not investment advice. Open the LVS and MGRX stock pages for the full models.
Not investment advice.